- Home
- RCUS vs FBRT Comparison
RCUS vs FBRT Comparison
Compare RCUS & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- FBRT
- Stock Information
- Founded
- RCUS 2015
- FBRT 2012
- Country
- RCUS United States
- FBRT United States
- Employees
- RCUS N/A
- FBRT N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- FBRT Real Estate Investment Trusts
- Sector
- RCUS Health Care
- FBRT Real Estate
- Exchange
- RCUS Nasdaq
- FBRT Nasdaq
- Market Cap
- RCUS 906.4M
- FBRT 933.1M
- IPO Year
- RCUS 2018
- FBRT 1985
- Fundamental
- Price
- RCUS $8.36
- FBRT $10.90
- Analyst Decision
- RCUS Buy
- FBRT Strong Buy
- Analyst Count
- RCUS 10
- FBRT 6
- Target Price
- RCUS $23.75
- FBRT $15.25
- AVG Volume (30 Days)
- RCUS 1.2M
- FBRT 723.8K
- Earning Date
- RCUS 08-07-2025
- FBRT 07-30-2025
- Dividend Yield
- RCUS N/A
- FBRT 13.08%
- EPS Growth
- RCUS N/A
- FBRT N/A
- EPS
- RCUS N/A
- FBRT 0.67
- Revenue
- RCUS $141,000,000.00
- FBRT $175,693,000.00
- Revenue This Year
- RCUS N/A
- FBRT $29.44
- Revenue Next Year
- RCUS $28.73
- FBRT $2.22
- P/E Ratio
- RCUS N/A
- FBRT $16.21
- Revenue Growth
- RCUS N/A
- FBRT N/A
- 52 Week Low
- RCUS $6.50
- FBRT $10.50
- 52 Week High
- RCUS $18.98
- FBRT $14.12
- Technical
- Relative Strength Index (RSI)
- RCUS 39.01
- FBRT 38.53
- Support Level
- RCUS $7.91
- FBRT $10.57
- Resistance Level
- RCUS $8.87
- FBRT $11.13
- Average True Range (ATR)
- RCUS 0.48
- FBRT 0.17
- MACD
- RCUS -0.14
- FBRT 0.00
- Stochastic Oscillator
- RCUS 8.24
- FBRT 15.61
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.